A randomized phase III trial on maintenance treatment with bevacizumab (bev) alone or in combination with erlotinib (erlo) after chemotherapy and bev in metastatic colorectal cancer (mCRC)

Anders Johnsson, J.E. Frodin, A. Berglund, H. Hagman, J. Sundberg, D. Bergstrøm, René dePont Christensen, Nina Keldsen, Karen-Lise Garm Spindler, Anders Jakobsen

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskning

OriginalsprogEngelsk
Publikationsdato2011
StatusUdgivet - 2011
BegivenhedASCO Annual Meeting 2011 - Chicago, USA
Varighed: 3. jun. 20117. jun. 2011

Konference

KonferenceASCO Annual Meeting 2011
LandUSA
ByChicago
Periode03/06/201107/06/2011

Citer dette

Johnsson, A., Frodin, J. E., Berglund, A., Hagman, H., Sundberg, J., Bergstrøm, D., ... Jakobsen, A. (2011). A randomized phase III trial on maintenance treatment with bevacizumab (bev) alone or in combination with erlotinib (erlo) after chemotherapy and bev in metastatic colorectal cancer (mCRC). Abstract fra ASCO Annual Meeting 2011, Chicago, USA.
Johnsson, Anders ; Frodin, J.E. ; Berglund, A. ; Hagman, H. ; Sundberg, J. ; Bergstrøm, D. ; Christensen, René dePont ; Keldsen, Nina ; Spindler, Karen-Lise Garm ; Jakobsen, Anders. / A randomized phase III trial on maintenance treatment with bevacizumab (bev) alone or in combination with erlotinib (erlo) after chemotherapy and bev in metastatic colorectal cancer (mCRC). Abstract fra ASCO Annual Meeting 2011, Chicago, USA.
@conference{1660398ef893434e8ff95ee72abb9668,
title = "A randomized phase III trial on maintenance treatment with bevacizumab (bev) alone or in combination with erlotinib (erlo) after chemotherapy and bev in metastatic colorectal cancer (mCRC)",
author = "Anders Johnsson and J.E. Frodin and A. Berglund and H. Hagman and J. Sundberg and D. Bergstr{\o}m and Christensen, {Ren{\'e} dePont} and Nina Keldsen and Spindler, {Karen-Lise Garm} and Anders Jakobsen",
year = "2011",
language = "English",
note = "null ; Conference date: 03-06-2011 Through 07-06-2011",

}

Johnsson, A, Frodin, JE, Berglund, A, Hagman, H, Sundberg, J, Bergstrøm, D, Christensen, RD, Keldsen, N, Spindler, K-LG & Jakobsen, A 2011, 'A randomized phase III trial on maintenance treatment with bevacizumab (bev) alone or in combination with erlotinib (erlo) after chemotherapy and bev in metastatic colorectal cancer (mCRC)', ASCO Annual Meeting 2011, Chicago, USA, 03/06/2011 - 07/06/2011.

A randomized phase III trial on maintenance treatment with bevacizumab (bev) alone or in combination with erlotinib (erlo) after chemotherapy and bev in metastatic colorectal cancer (mCRC). / Johnsson, Anders; Frodin, J.E.; Berglund, A.; Hagman, H.; Sundberg, J.; Bergstrøm, D.; Christensen, René dePont; Keldsen, Nina; Spindler, Karen-Lise Garm; Jakobsen, Anders.

2011. Abstract fra ASCO Annual Meeting 2011, Chicago, USA.

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskning

TY - ABST

T1 - A randomized phase III trial on maintenance treatment with bevacizumab (bev) alone or in combination with erlotinib (erlo) after chemotherapy and bev in metastatic colorectal cancer (mCRC)

AU - Johnsson, Anders

AU - Frodin, J.E.

AU - Berglund, A.

AU - Hagman, H.

AU - Sundberg, J.

AU - Bergstrøm, D.

AU - Christensen, René dePont

AU - Keldsen, Nina

AU - Spindler, Karen-Lise Garm

AU - Jakobsen, Anders

PY - 2011

Y1 - 2011

M3 - Conference abstract for conference

ER -

Johnsson A, Frodin JE, Berglund A, Hagman H, Sundberg J, Bergstrøm D et al. A randomized phase III trial on maintenance treatment with bevacizumab (bev) alone or in combination with erlotinib (erlo) after chemotherapy and bev in metastatic colorectal cancer (mCRC). 2011. Abstract fra ASCO Annual Meeting 2011, Chicago, USA.